2019 Conference on Retroviruses and Opportunistic Infections (CROI)

Protocol

Title

Authors

Presentation Type

Tuesday, 5 March

P1081	Randomized trial of raltegravir-ART vs. efavirenz-ART when initiated during pregnancy	Mirochnick M, Shapiro DE, Morrison L, Frenkel L, Chakhtoura N, Siberry GK, Best B, Cruz MLS, Mmbaga BT, Pilotto JHS, Violari A, Prommas S, Joao E, for the NICHD P1081 Protocol Team	Oral presentation, Room 6C, 10:00 AM – 12:00 PM
HPTN 046	Maternal HBV viremia is associated with adverse infant outcomes in HIV/HBV women	Bhattacharya D, Guo R, Tseng C, Emel L, Sun R, Chiu S, Stranix-Chibanda L, Chipato T, Mohtashemi NZ, Kintu K, Manji KP, Moodley D, Thio C, Maldonado Y, Currier J	Oral presentation, Room 6C, 10:00 AM – 12:00 PM
P1112	Safety and pharmacokinetics of monoclonal antibody VRC01LS in HIV-exposed newborns	McFarland EJ, Cunningham CK, Capparelli EV, Muresan P, Smith E, Perlowski C, Morrison L, Morgan P, McDermott AB, Hazra R, Mascola JR, Graham B	Oral presentation, Room 6C, 10:00 AM – 12:00 PM
PROMISE 1077BF	Preterm birth among women with ultrasound-based gestational dating in PROMISE 1077BF	Venkatesh KK, Farhad M, Fenton T, Moodley D, Naik S, Nakabiito C, Fairlie L, Makanani B, Saidi F, Chipato T, McIntyre J, Fowler MG, Chi BH, Stringer JSA, for the PROMISE 1077BF team	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM

Wednesday, 6 March

Lab	Entry kinetics of globally representative and vertically transmitted HIV envelopes	Webb NE, Tobin N, Aldrovandi GM	Poster presentation and themed discussion, Room 606-609, 1:30 PM – 2:30 PM
Lab/ PACTG 338 and 377	Genomics links autophagy with neurocognitive impairment in HIV-infected children	Spector SA, Brummel SS, Singh KK, Kim J, Frazer KA, Nichols S, Seage III GR, Williams P, Van Dyke RB, Harismendy O, Trout RN	Poster presentation and themed discussion, Room 6E, 1:30 PM – 2:30 PM
P1072 and NWCS 612	Differences in gut microbial diversity in HIV infected vs exposed, uninfected infants	Koay WLA, Koh H, Bwakura-Dangarembizi M, Levin MJ, Weinberg A, Zhao N, Persaud D	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
Lab	Joint effects of HIV and obesity on the microbiome of young men who have sex with men	Cook RR, Fulcher JA, Tobin NH, Li F, Lee D, Javanbakht M, Brookmeyer R, Shoptaw S, Bolan R, Woodward C, Zabih S, Aldrovandi GM, Gorbach PM	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
Lab	Rectal microbiome alterations associated with TDF/FTC for pre-exposure prophylaxis	Fulcher JA, Li F, Cook RR, Zabih S, Woodward C, Louie A, Okochi H, Tobin NH, Gandhi M, Shoptaw S, Gorbach PM, Aldrovandi GM	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
PROMISE 1077BF/FF	HIV drug resistance at perinatal transmission and accumulation during breastfeeding	Boyce CL, Beck IA, Sils T, Ko D, Wong-on-Wing A, Styrchak S, DeMarrais P, Tierney C, Stranix-Chibanda L, Taha TE, Owor M, Fowler MG, Frenkel LM, for the Promoting Maternal and Infant Survival Everywhere trial (PROMISE) Study Team	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
P1115	Virologic response to very early ART in neonates with in utero HIV: IMPAACT P1115	Persaud D, Chadwick EG, Tierney C, Nelson B, Cotton M, Coletti A, Ruel T, Bwakura-Dangarembizi M, Mallewa M, Naidoo K, Reding C, Hazra R, Jean-Philippe P, Bryson Y, and the IMPAACT P1115 Team	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM

Thursday, 7 March

PROMISE 1077BF	Tenofovir hair levels rise over the postpartum period and highly predict viral loads	Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Kuncze K, Hoffman R, Nematadzira T, Soko D, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
PROMISE	Evaluation of guidelines for VL monitoring in pregnancy & breastfeeding: a simulation	Lesosky M, Raboud JM, Glass T, Brummel SS, Ciaranello AL, Currier JS, Essajee S, Havlir DV, Koss CA, Ogwu A, Shapiro RL, Abrams EJ, Myer L	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
P1078	Pregnancy associated with decreased serum isoniazid levels in women living with HIV	Gausi K, Denti P, Norman J, Wallis C, Onyango-Makumbi C, Chipato T, Theron G, Bradford S, Costello D, Browning N, Chakhtoura N, Weinberg A, Montepiedra G, Gupta A, and the IMPAACT P1078 (TB APPRISE) Study Group Team	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
P1093	PK and 4-week outcomes of dolutegravir dispersible tablets in HIV-infected children	Ruel T, Acosta E, Singh R, Alvero C, George K, Popson S, Bartlett M, Buchanan A, Brothers C, Koech L, Vhembo T, Hazra R, Townley E, Wiznia A, and the P1093 team	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM
HPTN 046	Extended prophylaxis with nevirapine does not affect growth in HIV-exposed infants	Onyango-Makumbi C, Mwiru RS, Owora AH, Mwatha A, Young AM, Moodley D, Coovadia HM, Stranix-Chibanda L, Manji K, Maldonado Y, Richardson P, Andrew P, George K, Fawzi W, Fowler MG	Poster presentation, Poster Hall – 4EF, 2:30 PM – 4:30 PM